Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 111

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 111
---
ach,                 12/04/2019          200      87.00      12/04/2026                              
  Matthias                 12/14/2020          250      36.60      12/14/2027                              
                           12/17/2021          500      42.05      12/17/2028                              
  Ammer,                   12/04/2019          250      87.00      12/04/2026                              
  Nicola                   12/14/2020          250      36.60      12/14/2027                              
                           12/17/2021          500      42.05      12/17/2028                              
  Teifel, Michael          12/17/2021          500      42.05      12/17/2028                              
  Reigner, Michell         05/01/2023        3,540      18.02      05/01/2028                              

  (1)      The number of securities underlying                                             

  (2)      “ Value of unexercised in-the-money                                                                                                      

  (3)      The Company used the closing price of its Common Shares on the                      

  76  

For the financial year ended December 31, 2024, the
Board approved did not approve any issuance of stock option awards to any of the Named Executives.

Incentive Plan Awards - Value Vested or Earned
During the Year

The following table shows the incentive plan awards
value vested or earned for each Named Executive Officer for the financial year ended December 31, 2024:

  Gagnon, Gilles       
  La Fratta, Giuliano  
  Gerlach, Matthias    
  Guenther, Eckhard    
  Ammer, Nicola        
  Teifel, Michael      
  Reigner, Michell     
 ───────────────────────

  (1)      Represents the aggregate dollar                                                                                                            

Summary Compensation Table

The Summary Compensation Table set forth below shows
compensation information for each of the Named Executive Officers for services rendered in all capacities during each of the financial
years ended December 31, 2024, 2023 and 2022. All amounts in the table below are in U. S. dollars. Ms. Auld’s and Mr. La Fratta’s
cash payments